BioSignal is a neuro diagnostic company providing functional brain assessment capabilities anywhere, at any time, for everyone. BioSignal improves brain function assessment in traditional medical settings such as neurology departments, epilepsy and sleep centers, ICUs, and neurology practices and clinics. We introduce brain function assessment in novel medical settings such as Emergency Departments, NICU, private physician’s practices, hospice, home care, and home sleep monitoring. We empower people to use brain function assessment for military medicine, youth recreation, and professional sports medicine, consumer fitness, and personal safety. Our microEEG® solution combines an FDA approved, miniature, wireless clinical platform technology capable of recording electroencephalograms (EEG) that is fast, portable, and easy-to-use with an interpretive platform allowing for rapid, remote interpretation. This portable and easy-to-use brain monitoring system is designed for use in emergency rooms, clinics, ICUs, epilepsy and sleep centers, physicians' offices, ambulances, schools, sports fields and anywhere else that benefits from rapid EEG.
Looking for a particular BioSignal Group employee's phone or email?
The BioSignal Group annual revenue was $5.3 million in 2026.
Sheila Hill is the Director of Operations of BioSignal Group.
1 people are employed at BioSignal Group.
The NAICS codes for BioSignal Group are [334, 33].
The SIC codes for BioSignal Group are [38, 384].